Inactivating GGTase-I reduces disease phenotypes in a mouse model of K-RAS-induced myeloproliferative disease

被引：15
|
作者：
Sjogren, A-K M. [1 ]
Andersson, K. M. E. [1 ]
Khan, O. [1 ]
Olofsson, F. J. [1 ]
Karlsson, C. [1 ]
Bergo, M. O. [1 ]
机构：
[1] Sahlgrens Univ Hosp, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden
来源：
LEUKEMIA | 2011年 / 25卷 / 01期
关键词：
GERANYLGERANYLTRANSFERASE-I; ONCOGENIC KRAS; CELLS; INHIBITORS; MICE;
D O I：
10.1038/leu.2010.242
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：186 / 189
页数：5
相关论文
共 50 条
  • [1] Inactivating GGTase-I reduces disease phenotypes in a mouse model of K-RAS-induced myeloproliferative disease
    A-K M Sjogren
    K M E Andersson
    O Khan
    F J Olofsson
    C Karlsson
    M O Bergo
    Leukemia, 2011, 25 : 186 - 189
  • [2] Inactivating Icmt ameliorates K-RAS-induced myeloproliferative disease
    Wahlstrom, Annika M.
    Cutts, Briony A.
    Liu, Meng
    Lindskog, Annika
    Karlsson, Christin
    Sjogren, Anna-Karin M.
    Andersson, Karin M. E.
    Young, Stephen G.
    Bergo, Martin O.
    BLOOD, 2008, 112 (04) : 1357 - 1365
  • [3] GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer
    Sjogren, Anna-Karin M.
    Andersson, Karin M. E.
    Liu, Meng
    Cutts, Briony A.
    Karlsson, Christin
    Wahlstrom, Annika M.
    Dalin, Martin
    Weinbaum, Carolyn
    Casey, Patrick J.
    Tarkowski, Andrej
    Swolin, Birgitta
    Young, Stephen G.
    Bergo, Martin O.
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05): : 1294 - 1304
  • [4] WOULD INACTIVATION OF GGTASE-I PREVENT THE DEVELOPMENT OF K-RAS-INDUCED MPD IN MICE?
    Sjogren, A. -K.
    Andersson, K. M. E.
    Cutts, B. A.
    Karlsson, C.
    Khan, O.
    Liu, M.
    Bergo, M. O.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 117 - 118
  • [5] Targeting ICMT ameliorates K-RAS-induced myeloproliferative disease and lung cancer
    Bergo, M.
    Wahlstrom, A. M.
    Liu, M.
    Karlsson, C.
    Swolin, B.
    Cutts, B. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 345 - 346
  • [6] Rce1 deficiency accelerates the development of K-RAS-induced myeloproliferative disease
    Wahlstrom, Annika M.
    Cutts, Briony A.
    Karlsson, Christin
    Andersson, Karin M. E.
    Liu, Meng
    Sjogren, Anna-Karin M.
    Swolin, Birgitta
    Young, Stephen G.
    Bergo, Martin O.
    BLOOD, 2007, 109 (02) : 763 - 768
  • [7] Targeting FTase and GGTase-1 efficiently reduces tumor development and improves survival in mice with K-RAS-induced lung cancer
    Sjogren, Anna-Karin
    Liu, Meng
    Karlsson, Christin
    Ibrahim, Mohamed
    Young, Stephen
    Bergo, Martin
    CANCER RESEARCH, 2009, 69
  • [8] Promotion of Lung Carcinogenesis by Chronic Obstructive Pulmonary Disease-Like Airway Inflammation in a K-ras-Induced Mouse Model
    Moghaddam, Seyed Javad
    Li, Huaiguang
    Cho, Sung-Nam
    Dishop, Megan K.
    Wistuba, Ignacio I.
    Ji, Lin
    Kurie, Jonathan M.
    Dickey, Burton F.
    DeMayo, Francesco.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2009, 40 (04) : 443 - 453
  • [9] Oncogenic K-ras in mouse models of myeloproliferative disease and acute myeloid leukemia
    Chan, IT
    Gilliland, DG
    CELL CYCLE, 2004, 3 (05) : 536 - 537
  • [10] Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease
    Sanchis, Ana
    Adelaida Garcia-Gimeno, Maria
    Jose Canada-Martinez, Antonio
    Dolores Sequedo, Maria
    Maria Millan, Jose
    Sanz, Pascual
    Vazquez-Manrique, Rafael P.
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 51 (6): : 1 - 16
12345